ArticleMediterranean journal of rheumatology2026
Unilateral Renal Artery Vasculitis: A Case Report.
Article in Mediterranean journal of rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal artery inflammation is typically observed as part of systemic vasculitis rather than as an isolated condition. Large vessel vasculitides, such as Takayasu arteritis and giant cell arteritis, as well as polyarteritis nodosa, may involve multiple vessels, including the renal artery. Isolated vasculitis of the renal artery is exceedingly rare with only eight cases reported worldwide. We describe a case of a previously healthy 53-year-old man who presented with a history of right flank pain which was attributed to renal artery vasculitis. Extensive radiologic studies revealed no evidence of inflammation in other vessels and laboratory evaluation for an underlying infectious, neoplastic or autoimmune cause was negative. Treatment with methylprednisolone, followed by azathioprine as a steroid-sparing agent, led to complete remission of the condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.